General objectives are to: increase the development of medicinal products for use in children, ensure that medicinal products used to treat children are subject to high quality research, ensure that medicinal products used to treat children are appropriately authorised for use in children, improve the information available on the use of medicinal products in children.
His ethical reforms, in a trade that was marked by outlandish claims of miracle medicines, began a period of rapid advancement in the development of medicinal drugs.
Churilov [18] has demonstrated that ultra disperse metal powder had stimulated growth and development of medicinal plants.
The rapidly changing sociopolitical marijuana landscape provides a foundation for the therapeutic development of medicinal cannabidiol to address the current opioid abuse crisis.
For adult dosage forms the use of biopharmaceutical tools to aid in the design and development of medicinal products is well documented.
Consequently, the commercial development of medicinal plants and their derivatives, such as essential oils, as new sources of bioactive products to enhance human health and food preservation is of prime importance.
Thus far, neither vaccines nor medications are available to treat or control the virus and therefore, the development of medicinal chemistry is a vital and immediate issue that needs to be addressed.
Regulators acknowledge that the development of medicinal products is evolving in terms of conduct and focus.
In Europe, the EMEA Paediatric Committee has identified the needs in different therapeutic areas where there should be research and development of medicinal products for children [ 2].
The etiology of metabolic disease is complex, with diverse pathophysiological mechanisms, emphasizing the challenges inherent in the development of medicinal options for the disorder (Kopelman, 2000; Scheen & Van Gaal, 2014).
The Regulation contains a shared responsibility between European Commission (EC) and Member States (MSs) in respect of incentives for research and development of medicinal products for paediatric use and for placing such products on the market, within the framework of their own powers and responsibilities.
